SCHEMBL16826290

SCHEMBL16826290

Nc1n[nH]c(N2CC3CN(CCOc4ccc(Br)cc4)CC3C2)n1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHIA Q9BZP6 2/20 0.54
▸ CHIT1 Q13231 1/20 0.54
▸ KDM4E B2RXH2 3/20 0.43
▸ SMN1; SMN2 Q16637 1/20 0.43
▸ LTA4H P09960 1/20 0.41
▸ PTGS2 P35354 1/20 0.41
▸ RAB9A P51151 2/20 0.39
▸ NPC1 O15118 1/20 0.39
▸ TP53 P04637 1/20 0.39
▸ CYP1A2 P05177 1/20 0.39
▸ GAA P10253 1/20 0.39
▸ HSD17B10 Q99714 1/20 0.39
▸ KMT2A Q03164 1/20 0.39
▸ KDM1A O60341 1/20 0.39
▸ HTR1A P08908 1/20 0.37
▸ HTR7 P34969 1/20 0.37
▸ TSHR P16473 1/20 0.37
▸ DRD3 P35462 1/20 0.37
▸ ATM Q13315 1/20 0.36
▸ L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16826340 0.86 CHIA (0.67) CHIACHIT1KDM4ELTA4HPTGS2
SCHEMBL16825716 0.82 CHIA (0.62) CHIACHIT1KDM4ELTA4HPTGS2
SCHEMBL16825794 0.79 CHIA (0.50) CHIACHIT1KDM4ESMN1; SMN2LTA4H
SCHEMBL18135548 0.74 CHIT1 (0.52) CHIACHIT1KDM4ESMN1; SMN2RAB9A
SCHEMBL16825821 0.74 CHIT1 (0.52) CHIACHIT1KDM4ESMN1; SMN2LTA4H
SCHEMBL16825681 0.74 CHIT1 (0.52) CHIACHIT1LTA4HKMT2AHTR1A
SCHEMBL16825820 0.74 CHIT1 (0.52) CHIACHIT1KDM4ELTA4HRAB9A
SCHEMBL16825744 0.74 CHIT1 (0.51) CHIACHIT1LTA4HHTR1ADRD3
SCHEMBL16825654 0.73 HRH2 (0.56) CHIACHIT1KDM4ESMN1; SMN2LTA4H
SCHEMBL16825839 0.71 CHIA (0.43) CHIACHIT1SMN1; SMN2RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3082805-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME The Institute For Drug Delivery (US) 2016-10-26 — — EP claimed
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INSTITUTE FOR DRUG DISCOVERY, LLC 2016-10-13 — — US claimed
WO-2015095701-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME THE INSTITUTE FOR DRUG DELIVERY (US) 2015-06-25 — — WO claimed
EP-3082805-B1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INST FOR DRUG DISCOVERY LLC (US) 2020-02-05 — — EP disclosed
EP-3082805-B1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INST FOR DRUG DISCOVERY LLC (US) 2020-02-05 — — EP disclosed
EP-3082805-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME The Institute For Drug Delivery (US) 2016-10-26 — — EP disclosed
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INSTITUTE FOR DRUG DISCOVERY, LLC 2016-10-13 — — US disclosed
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INSTITUTE FOR DRUG DISCOVERY, LLC 2016-10-13 — — US disclosed
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME INSTITUTE FOR DRUG DISCOVERY, LLC 2016-10-13 — — US disclosed
WO-2015095701-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME THE INSTITUTE FOR DRUG DELIVERY (US) 2015-06-25 — — WO disclosed
WO-2015095701-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME THE INSTITUTE FOR DRUG DELIVERY (US) 2015-06-25 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160297823-A1 SUBSTITUTED AMINO TRIAZOLES, AND METHODS USING SAME CMA1, CHIA, AADAC CHIA 2/4885CHIT1 11/4885KDM4E 2405/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback